Abstract:Objectives: Patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) combined with severe type II respiratory failure have a high probability of ventilation failure using conventional non-invasive positive pressure ventilation (NPPV). This study aims to investigate the clinical efficacy of high intensity NPPV (HI-NPPV) for the treatment of AECOPD combined with severe type II respiratory failure. Methods: The data of patients with AECOPD combined with severe type II respiratory failure (blood gas analysis pH≤7.25) treated with NPPV in the Second Affiliated Hospital of Chongqing Medical University from July 2013 to July 2023 were collected to conduct a retrospective case-control study. The patients were divided into 2 groups according to the inspired positive airway pressure (IPAP) used during the NPPV treatment: a NPPV group (IPAP<20 cmH2O, 1 cmH2O=0.098 kPa) and a HI-NPPV group (20 cmH2O≤IPAP< 30 cmH2O). Ninety-nine and 95 patients were included in the NPPV group and the HI-NPPV group, respectively. A total of 86 pairs of data were matched using propensity score matching (PSM) for data matching. The primary outcome indexes (mortality and tracheal intubation rate) and secondary outcome indexes [blood gas analysis pH, arterial partial pressure of oxygen (PaO2) and arterial partial pressure of carbon dioxide (PaCO2), adverse reaction rate, and length of hospitalization] were compared between the 2 groups. Results: The tracheal intubation rates of the NPPV group and the HI-NPPV group were 6.98% and 1.16%, respectively, and the difference between the 2 groups was statistically significant (χ2=4.32, P<0.05); the mortality of the NPPV group and the HI-NPPV group was 23.26% and 9.30%, respectively, and the difference between the 2 groups was statistically significant (χ2=11.64, P<0.01). The PaO2 at 24 h and 48 h after treatment of the HI-NPPV group was higher than that of the NPPV group, and the PaCO2 of the HI-NPPV group was lower than that of the NPPV group, and the differences were statistically significant (all P<0.05). The differences of pH at 24 h and 48 h after treatment between the 2 groups were not statistically significant (both P>0.05). The differences between the 2 groups in adverse reaction rate and hospitalization length were not statistically significant (both P>0.05). Conclusions: HI-NPPV can reduce mortality and tracheal intubation rates by rapidly improving the ventilation of patients with AECOPD combined with severe type II respiratory failure. This study provides a new idea for the treatment of patients with AECOPD combined with severe type II respiratory failure.

Clinical Efficacy Evaluation of Non-Invasive Positive Pressure Ventilation on Acute Coronary Syndrome Accompanied by Acute Left Heart Failure

Evaluation of the Effectivenesss of Noninvasive Positive Pressure Ventilation As a Weaning Strategy in Patients with Acute Respiratory Failure

Clinical Efficacy Evaluation of Non-Invasive Positive Airway Pressure Ventilation on Acute Cardiogenic Pulmonary Edema

Efficacy of Non-Invasive Ventilation in Acute Coronary Syndrome Patients with Acute Systolic Heart Failure

The use of noninvasive ventilation in the treatment of acute cardiogenic pulmonary edema

Clinical Study on Treatment of Acute Cardiogeni Cpulmonary Edema by Noninvasive Positive Pressure Ventilation

The Comparison Between the Continual Positive Airway Pressure Ventilation and the Bilevel Positive Airway Pressure Ventilation in Treating Acute Cardiogenic Pulmonary Edema

The clinic study of Non-invasive positive pressure ventilation (NIPPV) on 63 cases with typeⅠ respiratory failure

Non-invasive Positive Ventilation in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Hypercapnia Respiratory Failure

Bi-level Positive-Pressure Non-invasive Ventilation on Treatment of Acute Left Ventricular Failure

Noninvasive positive pressure ventilation in the treatment of cardiothoracic patients with acute respiratory failure

Clinical Investigation of Non-Invasive Positive Pressure Ventilation in Treatment for Patients with Chronic Obstructive Pulmonary Disease and Severe Respiratory Failure Complicated with Hypercapnia

The Effect of Bi-level Positive Airway Pressure Non-invasive Ventilation on the Treatment of Acute Left Ventricular Failure

Application of Noninvasive Positive-Pressure Ventilation in Patients With Acute Respiratory Failure After Cardiopulmonary Bypass Surgery

The Effects of Non-Invasive Ventilator in Treatment with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Observation of curative effects of noninvasive mechanical ventilation in the treatment of acute left heart failure

A Clinical Observation with Noninvasive Positive Pressure Mechanical Ventilation on COPD Elderly Patients with Type II Respiratory Failure

Clinical efficacy of HI-NPPV in the treatment of AECOPD combined with severe type II respiratory failure

Effect of Noninvasive Bi-Level Positive Airway Pressure Ventilation on Treatment of Acute Left Heart Failure Complicated with Respiratory Failure by Titration of Pressure

Efficacy of noninvasive positive pressure ventilation in the treatment of acute bronchial asthma with respiratory failure

Respiratory and Circulating Effects of Noninvasive Positive Pressure Ventilation in the Post-operation Patients with Acute Respiratory Failure